Geode Capital Management LLC Has $814,000 Holdings in PetMed Express, Inc. (NASDAQ:PETS)

Geode Capital Management LLC lessened its holdings in PetMed Express, Inc. (NASDAQ:PETS) by 5.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 221,230 shares of the company’s stock after selling 12,331 shares during the period. Geode Capital Management LLC owned 1.07% of PetMed Express worth $814,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of PETS. Federated Hermes Inc. lifted its stake in shares of PetMed Express by 54.5% in the 2nd quarter. Federated Hermes Inc. now owns 606,430 shares of the company’s stock valued at $2,456,000 after purchasing an additional 213,903 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in shares of PetMed Express in the 2nd quarter valued at $797,000. Bleakley Financial Group LLC acquired a new stake in shares of PetMed Express in the 3rd quarter valued at $279,000. Squarepoint Ops LLC acquired a new stake in shares of PetMed Express in the 2nd quarter valued at $273,000. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of PetMed Express in the 2nd quarter valued at $135,000. Institutional investors and hedge funds own 73.33% of the company’s stock.

Insider Transactions at PetMed Express

In related news, Director Leslie C.G. Campbell acquired 15,000 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were bought at an average price of $5.38 per share, for a total transaction of $80,700.00. Following the acquisition, the director now owns 70,000 shares in the company, valued at $376,600. This trade represents a 27.27 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 1.10% of the company’s stock.

PetMed Express Price Performance

Shares of PETS opened at $4.77 on Friday. The company has a market capitalization of $98.56 million, a PE ratio of -79.50 and a beta of 0.69. PetMed Express, Inc. has a one year low of $2.90 and a one year high of $7.40. The company’s fifty day moving average price is $5.04 and its 200 day moving average price is $4.15.

PetMed Express (NASDAQ:PETS) last announced its earnings results on Wednesday, November 6th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of ($0.06) by $0.17. The firm had revenue of $59.57 million for the quarter, compared to the consensus estimate of $66.02 million. PetMed Express had a negative net margin of 0.37% and a negative return on equity of 1.00%. Analysts anticipate that PetMed Express, Inc. will post 0.24 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a report on Tuesday, November 12th.

PetMed Express Profile

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.